Hosted on MSN7mon
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma GiantThe active ingredient is different from other psychedelic ... who received a single intravenous dose of DMT followed by three different doses of the buccal formulation, administered 28 days ...
R esearchers assessed whether combining psychedelics, namely DMT and harmine as two active ingredients in ayahuasca, with meditation increases mindfulness, compassion, insight, and mystical-type ...
So Small Pharma has focused on another psychedelic drug, DMT. This is one of the active ingredients of the traditional Amazonian herbal medicine ayahuasca and it is also found endogenously in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results